Charles River Laboratories (United States)

Charles River Laboratories (United States)

Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in preclinical and clinical laboratory, gene therapy and cell therapy services and supplies for the pharmaceutical, medical device and biotechnology industries. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Charles River Laboratories (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

48%


Total
Publications

2.5K


Total Open
Publications

1.2K


Total
Citations

46K


Open Access
Percentage

48%


Total
Publications

2.5K


Total Open
Publications

1.2K


Total
Citations

46K

Wikipedia

Website

download

Breakdown

23% 17% 6% 54%

Publisher Open

23%

Both

17%

Other Platform Open

6%

Closed

54%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160180200220240Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

29%OA Journal

OA Journal 29%

281

Hybrid 32%

301

No Guarantees 39%

373

Other Platform Open

Domain 80%

451

Institution 25%

144

Other Internet 20%

113

Public 2%

12

Preprint 0%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
452
DOI
Other Internet
100
Europe PMC
Domain
34
DANS - Data Archiving and Networked Services
Institution
31
Unknown Repository
Other Internet
14
Elsevier - Scopus
Institution
13
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
12
Figshare
Public
12
University of Cambridge - Apollo
Institution
10
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
7
1 / 10

Data updated 18 August 2025

Share

Share

Share